OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

CHARITY REGISTRATION NUMBER: 1184699

OURBRAINBANK CIO

Unaudited Financial Statements 31 December 2025

BURGESS HODGSON LIMITED

Camburgh House 27 New Dover Road Canterbury Kent CT1 3DN

OURBRAINBANK CIO

Financial Statements

Year ended 31 December 2025

Page
Trustees' annual report 1
Statement of financial activities 5
Statement of financial position 6
Notes to the financial statements 7

OURBRAINBANK CIO

Trustees' Annual Report

Year ended 31 December 2025

The trustees present their report and the unaudited financial statements of the charity for the year ended 31 December 2025.

Reference and administrative details

Registered charity name OURBRAINBANK CIO Charity registration number 1184699 Principal office 2 Florida Street London E2 6AL The trustees U Yunis F Thorne M J Wilson (Appointed 7 October 2025) A Coulson J Arnold-Forster R Clemmow S D Matthews A Bennett-Clemmow E Pilkington N Nuttall E S Bathers Accountants Burgess Hodgson Limited Camburgh House 27 New Dover Road Canterbury Kent CT1 3DN

1

OURBRAINBANK CIO

Trustees' Annual Report (continued)

Year ended 31 December 2025

Structure, governance and management

OurBrainBank in the UK is governed on a voluntary basis by its experienced UK Board of Trustees, which meets and engages regularly to provide direction, oversight and implementation of the charity's activities in the UK. We work closely with our colleagues at OurBrainBank US, with our UK Trustees joining global board meetings to collaborate across areas of strategic development and communications, operating globally where we can and independently for campaigns that reflect local context.

OurBrainBank also benefits from robust medical and patient advisors based in the US, co-headed by leading neuro-oncologists Fabio Iwamoto MD of Columbia University, and Lakshmi Nayak MD of Dana-Farber Cancer Institute. The advisors bring together a wide range of clinical specialists spanning neuro-surgery, psychiatry and neuro-oncology. The patient advisors include patients and caregivers.

In the past few years we have increasingly built links with international GBM medical and patient/carer communities and, in the UK, we have grown relationships with healthcare and wider stakeholders and are regular attendees at GBM and brain cancer-related events.

We also engage and collaborate with other brain tumour charities in the UK. It has been very important to understand the work that they are undertaking in this space and ensure that we are not duplicating or performing any work that overlaps with their activities. It has been our focus, since the launch of our white paper in 2023 to advocate and campaign alongside other charities for an increase in universal tissue freezing and storage as a basis for genomic sequencing. So it marks progress, and a sign of collaboration, that the issue is now part of the mainstream of GBM discourse and policy.

Objectives and activities

Created by the late Jessica Morris as a direct result of her own diagnosis, OurBrainBank is an innovative, patient-led movement designed to move glioblastoma (GBM) from terminal to treatable, powered by patients.

It is the first non-profit created by, for and with people with GBM, a rare and deadly brain cancer whose 5-year survival rate is 5%. Glioblastomas are the most common high grade (cancerous) primary brain tumour in adults. A glioblastoma is the fastest growing form of glioma brain tumour and is extremely difficult to treat.

OurBrainBank aims to raise awareness and understanding of GBM, improve standards of patient care and quality of life, and highlight the importance of GBM-focused research and clinical trials.

The objectives of OurBrainBank are:

Globally and in the UK, we engage with GBM patients and their carers through a variety of channels, and use our external channels, fundraising activities, advocacy and campaigning initiatives to reach wider stakeholders.

2

OURBRAINBANK CIO

Trustees' Annual Report (continued)

Year ended 31 December 2025

Achievements and performance

Throughout 2025 we actively contributed to shaping the stakeholder debate around GBM in the UK. We have been regular attendees and contributors at the All-Party Parliamentary Group on Brain Tumours. We submitted evidence to the report, published in June 2025, from the All-Party Parliamentary Group on Less Survivable Cancers, which urged the UK Government to prioritise faster diagnosis of less survivable cancers. Our chair also joined the Brain Tumour Charity to meet with the Department of Health and Social Care to discuss the barriers and issues facing brain tumour patients and carers. We are also regular attendees at the British Neuro-Oncology Society (BNOS) annual conference, attending again in 2025 to engage with health industry stakeholders and other charities.

A major focus of our work in 2025 and 2026 has been the creation of a collaborative patient and carer research project, together with a team from Imperial College London. It aims to better understand the experience of adult brain tumour patients from the UK, as well as their attitudes to risk and their experiences of accessing treatment outside of the standard care offered by the NHS.

We launched the survey at the BNOS conference in London in June 2025 and a quantitative survey has since been completed by more than 130 patients, carers and their families in the UK. In 2026 we have added a qualitative interview study with a UK patients and carers to understand their perspectives, motivations and personal experiences in more depth, adding first-person accounts of NHS care, overseas treatment, cost and risk.

Alongside this research study we have also commissioned a separate literature review paper from a specialist healthcare, technology and innovation consultancy, mapping the treatments that the survey uncovered, including vaccines, hyperthermia, virotherapy and personalised approaches -against the published evidence base, which we aim to have peer-reviewed and published in a specialist cancer policy journal.

We again attended BNOS in 2026 to provide the GBM medical community and stakeholders with an update of our research, publishing a poster at the conference, and plan to publish two reports later in 2026 - one covering the patient experience review, and a second covering the literature review.

Financial review

OurBrainBank currently has no full-time UK employees, but thanks to the generosity of individual donors and fundraisers, we have generated sufficient funds to undertake all these activities and were supported during 2024/25 by our first part-time Campaign and Communications Manager in the UK, Matthew Wilson who we are delighted to say has since joined us as a Trustee.

2025 saw a number of generous individual donations and energetic fundraisers in support of OBB UK. For example, Jam Bensilum and Milo Caiger-Smith, our founder Jessica's nephew, completed the Brighton marathon to raise more than £6,000 for OurBrainBank. In 2025 we were also delighted to receive a generous grant from The Foyle Foundation, for which we remain extremely grateful.

More recently, in 2026 we were also successful in the London Marathon ballot. We were so honoured and delighted by the efforts of Jayden Wilkinson who ran to support us, raising more than £2,600 in the process.

We are extremely grateful to these and many other donors and fundraisers for their support, which enables us to continue our ambitious work. We hope to use the funds to engage more support to grow our activities and continue our campaigning on behalf of all GBM patients in the UK.

We look forward to having more to report in our 2026 review.

3

OURBRAINBANK CIO

Trustees' Annual Report (continued)

Year ended 31 December 2025

The trustees' annual report was approved on .............................. and signed on behalf of the board of23 October 2026 trustees by:

J Arnold-Forster Chair and Trustee

4

OURBRAINBANK CIO

Statement of Financial Activities

Year ended 31 December 2025

2025 2025 2024
Unrestricted
funds Total funds Total funds
Note £ £ £
Income and endowments
Donations and legacies 4 28,786 28,786 27,711
  
Total income 28,786 28,786 27,711
  
Expenditure
Expenditure on charitable activities 5,6 17,276 17,276 20,939
  
Total expenditure 17,276 17,276 20,939
  
  
Net income and net movement in funds 11,510 11,510 6,772
  
Reconciliation of funds
Total funds brought forward 111,317 111,317 104,545
  
Total funds carried forward 122,827 122,827 111,317
  

The statement of financial activities includes all gains and losses recognised in the year. All income and expenditure derive from continuing activities.

The notes on pages 7 to 11 form part of these financial statements.

5

OURBRAINBANK CIO

Statement of Financial Position

31 December 2025

2025 2024
Note £ £
Current assets
Debtors 11 2,954 3,272
Cash at bank and in hand 120,413 108,585
 
123,367 111,857
Creditors: amounts falling due within one year 12 540 540
 
Net current assets 122,827 111,317
 
Total assets less current liabilities 122,827 111,317
 
Net assets 122,827 111,317
 
Unrestricted funds 122,827 111,317
 
Total charity funds 13 122,827 111,317
 

These financial statements were approved by the board of trustees and authorised for issue on ........................, and are signed on behalf of the board by:23 October 2026

J Arnold-Forster Chair and Trustee

The notes on pages 7 to 11 form part of these financial statements.

6

OURBRAINBANK CIO

Notes to the Financial Statements

Year ended 31 December 2025

1. General information

The charity is a public benefit entity and a registered charity in England and Wales and is unincorporated. The address of the principal office is 2 Florida Street, London, E2 6AL.

2. Statement of compliance

These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', the Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (Charities SORP (FRS 102)) and the Charities Act 2011.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through income or expenditure.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

There are no material uncertainties about the charity's ability to continue.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Foreign currencies

Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the statement of financial activities.

Fund accounting

Unrestricted funds are available for use at the discretion of the trustees to further any of the charity's purposes.

Designated funds are unrestricted funds earmarked by the trustees for particular future project or commitment.

Restricted funds are subjected to restrictions on their expenditure declared by the donor or through the terms of an appeal, and fall into one of two sub-classes: restricted income funds or endowment funds.

7

OURBRAINBANK CIO

Notes to the Financial Statements (continued)

Year ended 31 December 2025

3. Accounting policies (continued)

Incoming resources

All incoming resources are included in the statement of financial activities when entitlement has passed to the charity; it is probable that the economic benefits associated with the transaction will flow to the charity and the amount can be reliably measured. The following specific policies are applied to particular categories of income:

Resources expended

Expenditure is recognised on an accruals basis as a liability is incurred. Expenditure includes any VAT which cannot be fully recovered, and is classified under headings of the statement of financial activities to which it relates:

All costs are allocated to expenditure categories reflecting the use of the resource. Direct costs attributable to a single activity are allocated directly to that activity. Shared costs are apportioned between the activities they contribute to on a reasonable, justifiable and consistent basis.

8

OURBRAINBANK CIO

Notes to the Financial Statements (continued)

Year ended 31 December 2025

3. Accounting policies (continued)

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into.

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.

4. Donations and legacies

Unrestricted Total Funds Unrestricted Total Funds
Funds 2025 Funds 2024
£ £ £ £
Donations
Donations 28,786 28,786 27,711 27,711
   
Expenditure on charitable activities by fund type
Unrestricted Total Funds Unrestricted Total Funds
Funds 2025 Funds 2024
£ £ £ £
Support costs 17,276 17,276 20,939 20,939
   

5. Expenditure on charitable activities by fund type

6. Expenditure on charitable activities by activity type

Total funds Total fund
Support costs 2025 2024
£ £ £
Support costs 16,538 16,538 20,129
Governance costs 738 738 810
  
17,276 17,276 20,939
  
Analysis of support costs
Analysis of
support costs Total 2025 Total 2024
£ £ £
General office 4,502 4,502 1,174
Finance costs (1,084) (1,084) (959)
Subcontractor 13,120 13,120 19,914
  
16,538 16,538 20,129
  

7. Analysis of support costs

9

OURBRAINBANK CIO

Notes to the Financial Statements (continued)

Year ended 31 December 2025

8. Net income

Net income is stated after charging/(crediting):

----- Start of picture text -----
2025 2024
£ £
Foreign exchange differences 219 (47)
 
----- End of picture text -----

9. Staff costs

The average head count of employees during the year was Nil (2024: Nil).

No employee received employee benefits of more than £60,000 during the year (2024: Nil).

10. Trustee remuneration and expenses

No remuneration or other benefits from employment with the charity or a related entity were received by the trustees.

11. Debtors

2025 2024
£ £
Amounts owed by group undertakings 2,954 3,272
 
12. Creditors: amounts falling due within one year
2025 2024
£ £
Accruals and deferred income 540 540
 
13. Analysis of charitable funds
Unrestricted funds
At At
1 January 202 31 December
5 Income Expenditure 2025
£ £ £ £
General funds 111,317 28,786 (17,276) 122,827
   
At At
1 January 202 31 December
4 Income Expenditure 2024
£ £ £ £
General funds 104,545 27,711 (20,939) 111,317
   

10

OURBRAINBANK CIO

Notes to the Financial Statements (continued)

Year ended 31 December 2025

14. Analysis of net assets between funds

Unrestricted Total Funds
Funds 2025
£ £
Current assets 123,367 123,367
Creditors less than 1 year (540) (540)
 
Net assets 122,827 122,827
 
Unrestricted Total Funds
Funds 2024
£ £
Current assets 111,857 111,857
Creditors less than 1 year (540) (540)
 
Net assets 111,317 111,317
 

11